Concepedia

Synthesis, characterization and targeting chemotherapy for ovarian cancer of trastuzumab-SN-38 conjugates

Yuqin Yao, Lin Yu, Xiaolan Su, Yuxi Wang, Wenting Li, Yangpin Wu, Xiangzheng Cheng, Hang Zhang, Xian Wei, Hao Chen,

Journal of Controlled Release · 2015 · 36 citations · 35 references

DOI

Concepts

References

35

A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity

PR Twentyman, M Luscombe · British Journal of Cancer · 1987 · 984 citations · Full text

, , +9

Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer

Teemu T. Junttila, Guangmin Li, Kathryn L. Parsons et al. · Breast Cancer Research and Treatment · 2010 · 533 citations

, , +11

Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer

John M. Lambert, Ravi Chari · Journal of Medicinal Chemistry · 2014 · 532 citations

, , +17

<b>Endocytosis and Sorting of ErbB2 and the Site of Action of Cancer Therapeutics Trastuzumab and Geldanamycin</b>

Cary D. Austin, Ann M. De Mazière, Paul I. Pisacane et al. · Molecular Biology of the Cell · 2004 · 489 citations · Full text

, , +17

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

Laleh Amiri‐Kordestani, Gideon M. Blumenthal, Qiang Xu et al. · Clinical Cancer Research · 2014 · 345 citations

, , +17